Racializing Drug Design: Implications of Pharmacogenomics for Health Disparities
- 1 December 2005
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 95 (12), 2133-2138
- https://doi.org/10.2105/ajph.2005.068676
Abstract
Current practices of using “race” in pharmacogenomics research demands consideration of the ethical and social implications for understandings of group difference and for efforts to eliminate health disparities. This discussion focuses on an “infrastructure of racialization” created by current trajectories of research on genetic differences among racially identified groups, the use of race as a proxy for risk in clinical practice, and increasing interest in new market niches by the pharmaceutical industry. The confluence of these factors has resulted in the conflation of genes, disease, and race. I argue that public investment in pharmacogenomics requires careful consideration of current inequities in health status and social and ethical concerns over reifying race and issues of distributive justice.Keywords
This publication has 35 references indexed in Scilit:
- Pharmacological and Cultural Considerations in Alcohol Treatment Clinical Trials: Issues in Clinical Research Related to Race and EthnicityAlcohol: Clinical and Experimental Research, 2003
- MEDLINE definitions of race and ethnicity and their application to genetic researchNature Genetics, 2003
- Pharmacogenetics: the ethical issuesThe Pharmacogenomics Journal, 2003
- Ethical, social and legal issues in pharmacogenomicsThe Pharmacogenomics Journal, 2003
- Pharmacogenetics and pharmacoepidemiologyPharmacoepidemiology and Drug Safety, 2001
- Assessing the cost-effectiveness of pharmacogenomicsAAPS PharmSci, 2000
- Pharmacogenomics: The promise of personalized medicineAAPS PharmSci, 2000
- Drug-related morbidity and mortality. A cost-of-illness modelArchives of Internal Medicine, 1995
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and TaiwanesePharmacogenetics, 1994